WIPI2 Enhances the Vulnerability of Colorectal Cancer Cells to Erastin via Bioinformatics Analysis and Experimental Verification

Investigators analyzed the expression of WD Repeat Domain Phosphoinositide Interacting 2 (WIPI2) in colorectal cancer versus normal tissues through The Cancer Genome Atlas.